Literature DB >> 12018955

Comparative audit of intravenous lorazepam and diazepam in the emergency treatment of convulsive status epilepticus in children.

A Qureshi1, E Wassmer, P Davies, K Berry, W P Whitehouse.   

Abstract

There is little evidence on which to judge the optimal treatment for convulsive status epilepticus (CSE) in children. This study compares the effect of intravenous (iv) lorazepam with iv diazepam as the first line of treatment of CSE. We studied all children with prolonged seizures arriving in the Accident and Emergency (A&E) Department in two separate periods. In the first 6-month period iv diazepam was used as standard treatment, in the second 1-year period iv lorazepam was used. We measured latency to stopping of seizure and any adverse events. A successful treatment was defined as one in which the seizure clinically ceased within 15 minutes after siting the iv cannula, requiring no further treatment.Intravenous diazepam (0.32 mg kg (-1)) was used in 17 of 26 patients, whilst iv lorazepam (0.13 mg kg (-1)) was used in 31 of 59. There were no differences between the two groups regarding age, sex and seizure type.The seizure was successfully controlled 15 minutes after siting the iv cannula in 11 (65%) patients treated with diazepam (median time of 3 minutes) and in 20 (65%) patients treated with lorazepam (median time of 5 minutes). These preliminary results suggest that iv lorazepam may be as effective as iv diazepam. Copyright 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12018955     DOI: 10.1053/seiz.2001.0635

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  10 in total

Review 1.  Best evidence topic reports. Lorazepam or diazepam in paediatric status epilepticus.

Authors:  Vince Choudhery; Will Townend
Journal:  Emerg Med J       Date:  2006-06       Impact factor: 2.740

2.  Pharmacokinetics of intravenous lorazepam in pediatric patients with and without status epilepticus.

Authors:  James M Chamberlain; Edmund V Capparelli; Kathleen M Brown; Cheryl W Vance; Kathleen Lillis; Prashant Mahajan; Richard Lichenstein; Rachel M Stanley; Colleen O Davis; Stephen Gordon; Jill M Baren; John N van den Anker
Journal:  J Pediatr       Date:  2011-11-01       Impact factor: 4.406

3.  Challenges in the design and analysis of non-inferiority trials: a case study.

Authors:  Valerie Durkalski; Robert Silbergleit; Daniel Lowenstein
Journal:  Clin Trials       Date:  2011-09-15       Impact factor: 2.486

4.  Intravenous diazepam, midazolam and lorazepam in acute seizure control.

Authors:  Geeta Gathwala; Mayank Goel; Jagjit Singh; Kundan Mittal
Journal:  Indian J Pediatr       Date:  2011-06-29       Impact factor: 1.967

5.  Guidelines for the evaluation and management of status epilepticus.

Authors:  Gretchen M Brophy; Rodney Bell; Jan Claassen; Brian Alldredge; Thomas P Bleck; Tracy Glauser; Suzette M Laroche; James J Riviello; Lori Shutter; Michael R Sperling; David M Treiman; Paul M Vespa
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

Review 6.  Why won't it stop? The dynamics of benzodiazepine resistance in status epilepticus.

Authors:  Richard J Burman; Richard E Rosch; Jo M Wilmshurst; Arjune Sen; Georgia Ramantani; Colin J Akerman; Joseph V Raimondo
Journal:  Nat Rev Neurol       Date:  2022-05-10       Impact factor: 44.711

7.  Pharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions.

Authors:  Simon N Muchohi; Kenneth Obiero; Charles R J C Newton; Bernhards R Ogutu; Geoffrey Edwards; Gilbert O Kokwaro
Journal:  Br J Clin Pharmacol       Date:  2007-07-17       Impact factor: 4.335

Review 8.  Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children.

Authors:  Amy McTague; Timothy Martland; Richard Appleton
Journal:  Cochrane Database Syst Rev       Date:  2018-01-10

9.  Response to diazepam in children with malaria-induced seizures.

Authors:  M L Ikumi; S N Muchohi; E O Ohuma; G O Kokwaro; C R J C Newton
Journal:  Epilepsy Res       Date:  2008-09-19       Impact factor: 3.045

Review 10.  Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability.

Authors:  Adam Strzelczyk; Laurent M Willems; Ricardo Kienitz; Lara Kay; Isabelle Beuchat; Sarah Gelhard; Sophie von Brauchitsch; Catrin Mann; Alexandra Lucaciu; Jan-Hendrik Schäfer; Kai Siebenbrodt; Johann-Philipp Zöllner; Susanne Schubert-Bast; Felix Rosenow
Journal:  CNS Drugs       Date:  2022-08-16       Impact factor: 6.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.